Related Experiment Videos
[A case of lymphocytic interstitial pneumonia]
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|October 21, 1998
Summary
This case report details lymphocytic interstitial pneumonia (LIP) in a patient with a 27-year history of bronchial asthma. The study highlights the potential link between these conditions and the need for careful patient monitoring.
Area of Science:
- Pulmonology
- Pathology
- Immunology
Background:
- Lymphocytic interstitial pneumonia (LIP) is a rare lung disease characterized by interstitial infiltration of lymphocytes.
- Bronchial asthma is a chronic inflammatory airway disease.
- The co-occurrence of LIP and bronchial asthma is exceptionally rare, with limited understanding of their potential relationship.
Observation:
- A 56-year-old female presented with incidental bilateral reticulonodular lung shadows and hilar lymphadenopathy on chest X-ray.
- Further investigations revealed mediastinal lymphadenopathy and polyclonal hypergammaglobulinemia.
- A transcutaneous thoracoscopic lung biopsy confirmed interstitial lymphocytic infiltration around bronchioles, diagnosing LIP.
Findings:
- The patient had a 27-year history of bronchial asthma, making this the first reported case of LIP co-occurring with asthma.
- Diagnostic imaging showed diffuse reticulonodular shadows and lymphadenopathy.
- Histopathology confirmed small lymphocyte infiltration around bronchioles, characteristic of LIP.
Implications:
- The association between LIP and bronchial asthma remains unclear, necessitating further research into potential pathogenetic links.
- Despite being asymptomatic with preserved pulmonary function during a 2-year follow-up, LIP carries a potential risk of malignant lymphoproliferative disease.
- Long-term, careful monitoring of patients with LIP, especially those with co-existing conditions like asthma, is crucial for early detection of complications.